Browse > Article
http://dx.doi.org/10.5352/JLS.2021.31.10.885

Effects of Schisandrae Fructus and Corni Fructus Extracts on the Proliferation and Expression of Prostatic Hyperplasia-inducing Factors in Dihydrotestosterone-stimulated LNCaP Human Prostate Carcinoma Cells  

Kim, Min Yeung (Department of Biochemistry, Dong-eui University College of Korean Medicine)
Ji, Seon Yeong (Department of Biochemistry, Dong-eui University College of Korean Medicine)
Hwangbo, Hyun (Department of Biochemistry, Dong-eui University College of Korean Medicine)
Lee, Hyesook (Department of Biochemistry, Dong-eui University College of Korean Medicine)
Kim, Tae Hee (Hamsoapharm Central Research)
Yoon, Seonhye (R&D Center, Naturetech Co. Ltd.)
Kim, Hyun Jin (R&D Center, Naturetech Co. Ltd.)
Kim, Sung Yeon (BIO Center, Chungbuk Technopark)
Kim, Tae Jung (BIO Center, Chungbuk Technopark)
Kim, Min Ji (BIO Center, Chungbuk Technopark)
Jung, Ha Eun (BIO Center, Chungbuk Technopark)
Choi, Yung Hyun (Department of Biochemistry, Dong-eui University College of Korean Medicine)
Publication Information
Journal of Life Science / v.31, no.10, 2021 , pp. 885-897 More about this Journal
Abstract
Schisandrae Fructus (SF) and Corni Fructus (CF) have been used for a long time for the prevention and treatment of various diseases. Although reports have highlighted the possibility of inhibiting the onset and progression of benign prostatic hyperplasia (BPH), studies on related mechanisms are still lacking. In this study, we investigated the potential of SF and CF in improving BPH by using a dihydrotestosterone (DHT)-induced in vitro BPH model using LNCaP prostate carcinoma cells. According to our results, water and ethanol extracts of SF and CF significantly inhibited the proliferation of LNCaP cells by DHT treatment and markedly downregulated the expression of DHT-induced BPH biomarkers and growth factors. They also regulated the expression of apoptosis regulatory factors and significantly reduced DHT-mediated oxidative stress. In addition, the protective effect on major factors involved in the pathogenesis of BPH was more effective in the ethanol extract treatment group than in the water extract group. Furthermore, the improvement effect on BPH was higher in the 1:1 combined treatment group than in the ethanol extract alone treatment group of SF and CF, and 60% ethanol extracts showed a better effect than 40% ethanol extracts. Therefore, our findings demonstrate that SF and CF can protect against BPH by preventing the hyperproliferation of prostate cells through the inhibition of the androgen signaling pathway, which was correlated with their antioxidant activities. Therefore, SF and CF extracts may be useful in the clinical treatment of BPH, and the combination of these two extracts can be synergistic.
Keywords
Benign prostatic hyperplasia; Corni Fructus; Dihydrotestosterone; LNCaP prostate cells; Schisandrae Fructus;
Citations & Related Records
연도 인용수 순위
  • Reference
1 Chun, J. N., Cho, M., So, I. and Jeon, J. H. 2014. The protective effects of Schisandra chinensis fruit extract and its lignans against cardiovascular disease: a review of the molecular mechanisms. Fitoterapia 97, 224-233.   DOI
2 Hwangbo, H., Kwon, D. H., Choi, E. O., Kim, M. Y., Ahn, K. I., Ji, S. Y., Kim, J. S., Kim, K. I., Park, N. J., Kim, B. H., Kim, G. Y., Hong, S. H., Park, C., Jeong, J. S. and Choi, Y. H. 2018. Corni Fructus attenuates testosterone-induced benign prostatic hyperplasia by suppressing 5alpha-reductase and androgen receptor expression in rats. Nutr. Res. Pract. 12, 378-386.   DOI
3 Langan, R. C. 2021. Men's health: Benign prostatic hyperplasia. FP Essent. 503, 18-22.
4 Madersbacher, S., Sampson, N. and Culig, Z. 2019. Pathophysiology of benign prostatic hyperplasia and benign prostatic enlargement: A mini-review. Gerontology 65, 1-7.   DOI
5 Vafa, A., Afzal, S. M., Barnwal, P., Rashid, S., Shahid, A., Alpashree, Islam, J. and Sultana, S. 2020. Protective role of diosmin against testosterone propionate-induced prostatic hyperplasia in Wistar rats: Plausible role of oxidative stress and inflammation. Hum. Exp. Toxicol. 39, 1133-1146.   DOI
6 Hong, G. L., Park, S. R., Jung, D. Y., Karunasagara, S., Lee, K. P., Koh, E. J., Cho, K., Park, S. S. and Jung, J. Y. 2020. The therapeutic effects of Stauntonia hexaphylla in benign prostate hyperplasia are mediated by the regulation of androgen receptors and 5alpha-reductase type 2. J. Ethnopharmacol. 250, 112446.   DOI
7 Jahan, N., Chowdhury, A., Li, T., Xu, K., Wei, F. and Wang, S. 2021. Neferine improves oxidative stress and apoptosis in benign prostate hyperplasia via Nrf2-ARE pathway. Redox Rep. 26, 1-9.   DOI
8 Kim, E. H., Brockman, J. A. and Andriole, G. L. 2018. The use of 5-alpha reductase inhibitors in the treatment of benign prostatic hyperplasia. Asian J. Urol. 5, 28-32.   DOI
9 La Vignera, S., Condorelli, R. A., Russo, G. I., Morgia, G. and Calogero, A. E. 2016. Endocrine control of benign prostatic hyperplasia. Andrology 4, 404-411.   DOI
10 Minciullo, P. L., Inferrera, A., Navarra, M., Calapai, G., Magno, C. and Gangemi, S. 2015. Oxidative stress in benign prostatic hyperplasia: a systematic review. Urol. Int. 94, 249-254.   DOI
11 Ren, H., Li, X., Cheng, G., Li, N., Hou, Z., Suo, J., Wang, J. and Za, X. 2015. The effects of ROS in prostatic stromal cells under hypoxic environment. Aging Male 18, 84-88.   DOI
12 Choi, Y. J., Fan, M., Tang, Y., Yang, H. P., Hwang, J. Y. and Kim, E. K. 2019. In vivo effects of polymerized anthocyanin from grape skin on benign prostatic hyperplasia. Nutrients 11, 2444.   DOI
13 Banerjee, P. P., Banerjee, S., Brown, T. R. and Zirkin, B. R. 2018. Androgen action in prostate function and disease. Am. J. Clin. Exp. Urol. 6, 62-77.
14 Berger, A. P., Kofler, K., Bektic, J., Rogatsch, H., Steiner, H., Bartsch, G. and Klocker, H. 2003. Increased growth factor production in a human prostatic stromal cell culture model caused by hypoxia. Prostate 57, 57-65.   DOI
15 Cheon, S. Y., Jin, B. R., Kim, H. J. and An, H. J. 2020. Oleanolic acid ameliorates benign prostatic hyperplasia by regulating PCNA-dependent cell cycle progression in vivo and in vitro. J. Nat. Prod. 83, 1183-1189.   DOI
16 Dhurat, R., Sharma, A., Rudnicka, L., Kroumpouzos, G., Kassir, M., Galadari, H., Wollina, U., Lotti, T., Golubovic, M., Binic, I., Grabbe, S. and Goldust, M. 2020. 5-Alpha reductase inhibitors in androgenetic alopecia: Shifting paradigms, current concepts, comparative efficacy, and safety. Dermatol. Ther. 33, e13379.   DOI
17 Dong, Y., Feng, Z. L., Chen, H. B., Wang, F. S. and Lu, J. H. 2018. Corni Fructus: a review of chemical constituents and pharmacological activities. Chin. Med. 13, 34.   DOI
18 Huang, J., Zhang, Y., Dong, L., Gao, Q., Yin, L., Quan, H., Chen, R., Fu, X. and Lin, D. 2018. Ethnopharmacology, phytochemistry, and pharmacology of Cornus officinalis Sieb. et Zucc. J. Ethnopharmacol. 213, 280-301.   DOI
19 Halvorsen, O. J. 2008. Molecular and prognostic markers in prostate cancer. A study of cell-cycle regulators, angiogenesis and candidate markers. APMIS 123, 5-62.
20 Heinlein, C. A. and Chang, C. 2002. Androgen receptor (AR) coregulators: An overview. Endocr. Rev. 23, 175-200.   DOI
21 Karunasagara, S., Hong, G. L., Jung, D. Y., Kim, K. H., Cho, K. and Jung, J. Y. 2020. Protective effects of combination of Stauntonia hexaphylla and Cornus officinalis on testosterone-induced benign prostatic hyperplasia through inhibition of 5alpha- reductase type 2 and induced cell apoptosis. PLoS One 15, e0236879.   DOI
22 Kim, J. H., Park, K. M. and Lee, J. A. 2019. Herbal medicine for benign prostatic hyperplasia: A protocol for a systematic review of controlled trials. Medicine (Baltimore) 98, e14023.   DOI
23 Kopustinskiene, D. M. and Bernatoniene, J. 2021. Antioxidant effects of Schisandra chinensis fruits and their active constituents. Antioxidants (Basel) 10, 620.   DOI
24 Prajapati, A., Gupta, S., Mistry, B. and Gupta, S. 2013. Prostate stem cells in the development of benign prostate hyperplasia and prostate cancer: emerging role and concepts. Biomed. Res. Int. 2013, 107954.
25 Li, C., Hu, W. L., Lu, M. X. and Xiao, G. F. Resveratrol induces apoptosis of benign prostatic hyperplasia epithelial cell line (BPH-1) through p38 MAPK-FOXO3a pathway. BMC Complement. Altern. Med. 19, 233.   DOI
26 Ma, C. H., Lin, W. L., Lui, S. L., Cai, X. Y., Wong, V. T., Ziea, E. and Zhang, Z. J. 2013. Efficacy and safety of Chinese herbal medicine for benign prostatic hyperplasia: systematic review of randomized controlled trials. Asian J. Androl. 15, 471-482.   DOI
27 Minutoli, L., Rinaldi, M., Marini, H., Irrera, N., Crea, G., Lorenzini, C., Puzzolo, D., Valenti, A., Pisani, A., Adamo, E. B., Altavilla, D., Squadrito, F. and Micali, A. 2016. Apoptotic pathways linked to endocrine system as potential therapeutic targets for benign prostatic hyperplasia. Int. J. Mol. Sci. 17, 1311.   DOI
28 Rybnikar, M., Smejkal, K. and Zemlicka, M. 2019. Schisandra chinensis and its phytotherapeutical applications. Ceska. Slov. Farm. 68, 95-118.
29 Soulitzis, N., Karyotis, I., Delakas, D. and Spandidos, D. A. 2006. Expression analysis of peptide growth factors VEGF, FGF2, TGFB1, EGF and IGF1 in prostate cancer and benign prostatic hyperplasia. Int. J. Oncol. 29, 305-314.
30 Sampson, N., Koziel, R., Zenzmaier, C., Bubendorf, L., Plas, E., Jansen-Durr, P. and Berger, P. 2011. ROS signaling by NOX4 drives fibroblast-to-myofibroblast differentiation in the diseased prostatic stroma. Mol. Endocrinol. 25, 503-515.   DOI
31 Sowndhararajan, K., Deepa, P., Kim, M., Park, S. J. and Kim, S. 2018. An overview of neuroprotective and cognitive enhancement properties of lignans from Schisandra chinensis. Biomed. Pharmacother. 97, 958-968.   DOI
32 Srivilai, J., Minale, G., Scholfield, C. N. and Ingkaninan, K. 2019. Discovery of natural steroid 5 alpha-reductase inhibitors. Assay Drug Dev. Technol. 17, 44-57.   DOI
33 Czerwinska, M. E. and Melzig, M. F. 2018. Cornus mas and Cornus Officinalis-analogies and differences of two medicinal plants traditionally used. Front. Pharmacol. 9, 894.   DOI
34 Szopa, A., Ekiert, R. and Ekiert, H. 2017. Current knowledge of Schisandra chinensis (Turcz.) Baill. (Chinese magnolia vine) as a medicinal plant species: a review on the bioactive components, pharmacological properties, analytical and biotechnological studies. Phytochem. Rev. 16, 195-218.   DOI
35 Thomas, D., Chughtai, B., Kini, M. and Te, A. 2017. Emerging drug therapies for benign prostatic hyperplasia. Expert. Opin. Emerg. Drugs 22, 201-212.   DOI
36 Traish, A. M., Hassani, J., Guay, A. T., Zitzmann, M. and Hansen, M. L. 2011. Adverse side effects of 5alpha-reductase inhibitors therapy: Persistent diminished libido and erectile dysfunction and depression in a subset of patients. J. Sex. Med. 8, 872-884.   DOI
37 Velonas, V. M., Woo, H. H., Remedios, C. G. and Assinder, S. J. 2013. Current status of biomarkers for prostate cancer. Int. J. Mol. Sci. 14, 11034-11060.   DOI
38 Vickman, R. E., Franco, O. E., Moline, D. C., Vander Griend, D. J., Thumbikat, P. and Hayward, S. W. 2020. The role of the androgen receptor in prostate development and benign prostatic hyperplasia: A review. Asian J. Urol. 7, 191-202.   DOI
39 Jin, B. R., Cheon, S. Y., Kim, H. J., Kim, M. S., Lee, K. H. and An, H. J. 2020. Anti-proliferative effects of standardized Cornus officinalis on benign prostatic epithelial cells via the PCNA/E2F1-dependent cell cycle pathway. Int. J. Mol. Sci. 21, 9567.   DOI
40 Wei, F., He, X., Xu, K. and Wang, S. 2020. Stepwise frontal analysis coupled with cell membrane chromatography for affinity screening and characterization analysis of bioactive constituent from the mature fruits of schisandra chinensis. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 1161, 122443.   DOI
41 Bostanci, Y., Kazzazi, A., Momtahen, S., Laze, J. and Djavan, B. 2013. Correlation between benign prostatic hyperplasia and inflammation. Curr. Opin. Urol. 23, 5-10.   DOI
42 Li, Y., Huang, J., Lu, J., Ding, Y., Jiang, L., Hu, S., Chen, J. and Zeng, Q. 2019. The role and mechanism of Asian medicinal plants in treating skin pigmentary disorders. J. Ethnopharmacol. 245, 112173.   DOI
43 Wu, Y., Wang, X., Shen, B., Kang, L. and Fan, E. 2013. Extraction, structure and bioactivities of the polysaccharides from Fructus corni. Recent Pat Food Nutr. Agri. 5, 57-61.   DOI
44 Yeh, H. F., Li, T. F., Tsai, C. H., Wu, P. W., Huang, Y. H., Huang, W. J., Chen, F. J., Hwang, S. J., Chen, F. P. and Wu, T. P. 2020. The effects of a Chinese herbal medicine (VGHBPH0) on patients with benign prostatic hyperplasia: A pilot study. J. Chin. Med. Assoc. 83, 967-971.   DOI
45 Chu, K. F., Rotker, K. and Ellsworth, P. 2013. The impact of obesity on benign and malignant urologic conditions. Postgrad. Med. 125, 53-69.
46 Clement, C., Witschi, U. and Kreuzer, M. 2012. The potential influence of plant-based feed supplements on sperm quantity and quality in livestock: a review. Anim. Reprod. Sci. 132, 1-10.   DOI
47 Zhang, M., Xu, L. and Yang, H. 2018. Schisandra chinensis fructus and its active ingredients as promising resources for the treatment of neurological diseases. Int. J. Mol. Sci. 19, 1970.   DOI
48 Zhou, Y., Men, L., Sun, Y., Wei, M. and Fan, X. 2021. Pharmacodynamic effects and molecular mechanisms of lignans from Schisandra chinensis Turcz. (Baill.), a current review. Eur. J. Pharmacol. 892, 173796.   DOI
49 Zhou, Z., Cui, Y., Wu, J. and Jin, H. 2020. Efficacy and safety of dutasteride compared with finasteride in treating males with benign prostatic hyperplasia: A meta-analysis of randomized controlled trials. Exp. Ther. Med. 20, 1566-1574.   DOI
50 Zhu, P., Li, J., Fu, X. and Yu, Z. 2019. Schisandra fruits for the management of drug-induced liver injury in China: A review. Phytomedicine 59, 152760.   DOI
51 Gao, X., Liu, Y., An, Z. and Ni, J. 2021. Active components and pharmacological effects of Cornus officinalis: Literature review. Front. Pharmacol. 12, 633447.   DOI